In Silico Technologies in Drug Target Identification and Validation -

In Silico Technologies in Drug Target Identification and Validation

Darryl Leon, Scott Markel (Herausgeber)

Buch | Hardcover
508 Seiten
2006
Crc Press Inc (Verlag)
978-1-57444-478-0 (ISBN)
259,95 inkl. MwSt
From basic pre-screening target selection to genetic modeling and valuable data integration, this book examines experimental methods, modeling and computational techniques used to accelerate the drug target discovery process and assess the functionality of potential targets more effectively.
The pharmaceutical industry relies on numerous well-designed experiments involving high-throughput techniques and in silico approaches to analyze potential drug targets. These in silico methods are often predictive, yielding faster and less expensive analyses than traditional in vivo or in vitro procedures.

In Silico Technologies in Drug Target Identification and Validation addresses the challenge of testing a growing number of new potential targets and reviews currently available in silico approaches for identifying and validating these targets. The book emphasizes computational tools, public and commercial databases, mathematical methods, and software for interpreting complex experimental data. The book describes how these tools are used to visualize a target structure, identify binding sites, and predict behavior. World-renowned researchers cover many topics not typically found in most informatics books, including functional annotation, siRNA design, pathways, text mining, ontologies, systems biology, database management, data pipelining, and pharmacogenomics.

Covering issues that range from prescreening target selection to genetic modeling and valuable data integration, In Silico Technologies in Drug Target Identification and Validation is a self-contained and practical guide to the various computational tools that can accelerate the identification and validation stages of drug target discovery and determine the biological functionality of potential targets more effectively.

Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs. He also maintains a blog that explores organic chemistry.

Darryl Leon, Scott Markel

Foreword. Preface. Introduction.TARGET IDENTIFICATION: Pattern Matching. Tools for Computational Protein Annotation and Functional Assignment. The Impact of Genetic Variation on Drug Discovery and Development. Mining of Gene Expression Data. TARGET VALIDATION: Text Mining. Pathways and Networks. Molecular Interactions: Learning from Protein Complexes. In Silico siRNA Design. Predicting Protein Subcellular Localization Using Intelligent Systems. Three-Dimensional Structures in Target Discovery and Validation. RECENT TRENDS:Comparative Genomics. Pharmacogenomics. Target Identification and Validation Using Human Simulation Models. Using Protein Targets for In Silico Structure-Based Drug Discovery. COMPUTATIONAL INFRASTRUCTURE: Database Management. BioIT Hardware Configuration. BioIT Architecture: Software Architecture for Bioinformatics Research; Workflows and Data Pipelines. Ontologies. Index

Erscheint lt. Verlag 13.6.2006
Reihe/Serie Drug Discovery Series
Zusatzinfo 42 Tables, black and white; 3 Halftones, black and white; 9 Illustrations, color; 72 Illustrations, black and white
Verlagsort Bosa Roca
Sprache englisch
Maße 156 x 234 mm
Gewicht 839 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Naturwissenschaften Biologie
Technik
ISBN-10 1-57444-478-6 / 1574444786
ISBN-13 978-1-57444-478-0 / 9781574444780
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich